University of California San Francisco
Give to UCSF
Women May Be at Increased Health Risk Due to PTSD
<p><span>Research has shown that women are at greater risk of post-traumatic stress disorder (PTSD) than men. Now, scientists based at the UCSF-affiliated San Francisco Veterans Affairs Medical Center (SFVAMC) have found that women with the condition might be more likely to experience faster aging at the cellular level and increased risk for diseases of aging than men with PTSD.</span></p>
Helping Multiple Sclerosis Patients Face Dizzying Medication Decisions
<p>There is no cure for multiple sclerosis, but several medications can help slow its devastating effects, and extend healthier years for the roughly 2.5 million people worldwide diagnosed with this chronic neurological disease.</p>
Epilepsy Drug Could Help with Alzheimer's-Related Memory Loss
Scientists at the UCSF-affiliated Gladstone Institutes have discovered that an FDA-approved anti-epileptic drug reverses memory loss and alleviates other Alzheimer’s-related impairments in an animal model of the disease.
Increasing Dopamine in Frontal Cortex Decreases Impulsive Tendency, UCSF-Gallo Scientists Find
Raising levels of the neurotransmitter dopamine in the frontal cortex of the brain significantly decreased impulsivity in healthy adults, in a study conducted by researchers at the Ernest Gallo Clinic and Research Center at the University of California, San Francisco.
Gladstone Scientists Reprogram Skin Cells into Brain Cells
Scientists at the Gladstone Institutes have for the first time transformed skin cells — with a single genetic factor — into cells that develop on their own into an interconnected, functional network of brain cells.
Chronic Pain is Relieved by Cell Transplantation in Lab Study
Chronic pain, by definition, is difficult to manage, but a new study by UCSF scientists shows how a cell therapy might one day be used not only to quell some common types of persistent and difficult-to-treat pain, but also to cure the conditions that give rise to them.
Gladstone Scientists Identify Key Network Mechanism That Could Contribute to Cognitive Problems in Alzheimer's Disease
Scientists at the Gladstone Institutes have unraveled a process by which depletion of a specific protein in the brain contributes to the memory problems associated with Alzheimer’s disease. These findings provide insights into the disease’s development and may lead to new therapies that could benefit the millions of people worldwide.
How Selective Hearing Works In the Brain
<p>The longstanding mystery of how selective hearing works — how people can tune in to a single speaker while tuning out their crowded, noisy environs — is solved this week in the journal <em>Nature</em> by two scientists from the University of California, San Francisco (UCSF).</p>
Brain Cancer Vaccine Shows Promise
A new brain cancer vaccine tailored to individual patients by using material from their own tumors has proven effective in a multicenter phase 2 clinical trial at extending their lives by several months or longer. The patients suffered from recurrent glioblastoma multiform — which kills thousands of Americans every year.
